Berobenatide
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
Pfizer · Phase 3 · Recruiting · Enrollment 756
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.